申请人:Guangdong Newopp Biopharmaceuticals Co., Ltd.
公开号:US20200325161A1
公开(公告)日:2020-10-15
Heterocyclic compounds are provided as arginase inhibitors, in particular to a compound represented by Formula (I), or a pharmaceutically acceptable salt, stereoisomer or tautomer, or prodrug thereof and a pharmaceutical composition including the compound.